- Back to menuPrices
- Back to menuResearch
- Back to menuConsensus
- Back to menu
- Back to menu
- Back to menu
- Back to menuWebinars & Events
FM Clip
How Co:Create Helps NFT Projects Launch Their Own Tokens
Co:Create co-founder & CEO Tara Fung discusses how the Co:Create protocol provides the infrastructure for non-fungible token (NFT) projects and Web3 brands to scale through launching their own native tokens. Plus, her take on the legal considerations of digital collectibles.
Do Kwon Denies Claims He Is on the Run From Law Enforcement
"Unchained" Podcast Host and author Laura Shin discusses the key takeaways from her recent interview with Terraform Labs co-founder Do Kwon about the latest allegations against him in the $60 billion implosion of the Terra ecosystem.
Bitcoin Stuck Around $19K as October Bounce Remains Elusive
Bitcoin (BTC) was supposedly due for a recovery rally in the routinely bullish month of October, but the bounce has remained elusive with the token struggling around the $19,000 level. Two Sigma Ventures Principal Andy Kangpan joins Christine Lee and special co-host Laura Shin on “First Mover” with his bitcoin outlook amid crypto winter.
Pantera Capital Exec on How Venture Capital Is Investing in the Digital Economy
Venture capital (VC) funding for crypto startups sank 37% in Q3 to its lowest level in over a year. Pantera Capital Partner Lauren Stephanian discusses the state of VC crypto investing and institutional adoption. Plus, the impact and "pushback effect" of recent decentralized finance (DeFi) hacks on the industry.
Rep. Himes: There's Room for Both CBDCs and Private Stablecoins
Rep. Jim Himes (D-Conn.) joins "First Mover" live from CoinDesk's I.D.E.A.S. in New York City to discuss his outlook on cryptocurrency regulation in the U.S. He says there's "room for both" a private stablecoin and a central bank digital currency (CBDC). Plus, he discusses the timeline of a U.S. CBDC.
This Scientist-Turned-Founder Is Bridging Drug Discovery With Blockchain
Genetic Networks Founder and Chairman Gennaro D’Urso shares an example of a "frustrating" experience of bringing a drug to market by having to ask for funding from the government. "Usually it's money that prevents you from moving fast." He joined "First Mover" live at CoinDesk's I.D.E.A.S. to explain how PharmaDAO could solve this problem.
PoS Is a Better Hedge Against Inflation: Umee CEO
"In many ways, [proof-of-stake] is a better hedge against inflation," says Umee Founder and CEO Brent Xu. He adds that the argument for bitcoin as a hedge has been "disproven" in this high interest rate environment. He joins "First Mover" live from I.D.E.A.S. in New York City.
Investor Identity Co. Parallel Markets Is Live with 70 Financial Institutions, Aims for Retail Growth
Parallel Markets' digital "Passport" aims to make it easier for customers to invest across traditional banking and Web3 platforms. Co-Founder and CEO Tony Peccatiello says the platform is now live with 70 financial institutions and the goal is to expand to retail users. He's joined by Head of Partnerships Suzanne Elovic live from I.D.E.A.S. 2022 by CoinDesk
How PharmaDAO Could Disrupt Drug Discovery
Genetic Networks founder and chairman Gennaro D'Urso joins "First Mover" to discuss how PharmaDAO could change the future of the pharmaceutical industry following the fallout of a global pandemic.
Parallel Markets Execs on Bridging Digital Identity Verification Across Platforms
Parallel Markets, a global investor identity company, wants to reduce the tension of customer onboarding and verification for traditional and crypto-native firms. Parallel Markets Co-Founder and CEO Tony Peccatiello, along with President & Head of Partnerships Suzanne Elovic, join "First Mover" live from I.D.E.A.S. 2022 by CoinDesk, to share insights into how this works and the privacy implications.